Jonathan Montagu (LifeSciVC)
Valeant Pharma's Arguments About Drug Research Are Misleading And Wrong
Matthew Herper (Forbes)
New Blood [on Theranos]
Roger Parloff (Fortune)
Right to Try: Here we Go
Derek Lowe (In the Pipeline)
Pfizer: How Facebook can 'unblind' a clinical trial
Fiona Barry (Outsourcing Pharma)
Where Next for Biosimilars
Dr. Duncan Emerton (FirstWord Pharma and Biosimilarz Blog)
Be sure to also check out the guest post Duncan authored for BDD.
Threat Grows From Liver Illness Tied to Obesity
Anahad O'Connor (New York Times)
Feature on NASH, relevant to Intercept Pharma $ICPT, Galectin Therapeutics $GALT, Conatus Pharmaceuticals $CNAT and others.